Title: Li Ruihuan Meets with British Guests
Author:
Date: 1989-11-19
Edition: 1

Li Ruihuan Meets with British Guests

	New China News Agency, Beijing, November 18 — Today evening, Li Ruihuan, a member of the Standing Committee of the Political Bureau of the Communist Party of China Central Committee, met with Henry Winter, Chairman of the Board of Directors of the British company SmithKline Beecham, and his delegation at the Diaoyutai State Guesthouse.

	During the friendly conversation, Li Ruihuan highly praised the successful cooperation between SmithKline Beecham and China. He said, "This cooperation not only brings economic benefits to both sides but also the medicines produced have brought welfare to the Chinese people."

	Li Ruihuan said, "China's policy of reform and opening up will not change. We will prove this with concrete actions."

	SmithKline Beecham is a new company formed by the merger of the American company SmithKline Beckman and the British company Beecham, with its headquarters in London. It is the second-largest pharmaceutical company in the world. SmithKline Beecham has a joint venture with the Chinese side, establishing the Tianjin SmithKline Pharmaceutical Company.

	The delegation led by Winter is in China at the invitation of the China International Trust and Investment Corporation.


<hr /> 

Original: 


### 李瑞环会见英国客人

1989-11-19
第1版(要闻)
专栏：

    李瑞环会见英国客人
    新华社北京11月18日电  中共中央政治局常委李瑞环今天晚上在钓鱼台国宾馆会见了英国史克·必诚公司董事长亨利·温特一行。
    在友好的交谈中，李瑞环高度评价史克·必诚公司同中国的成功合作。他说，这个合作不但使双方经济上获得了利益，而且所生产的药品也给中国人民带来了福利。
    李瑞环说，中国改革开放政策不变。对此，我们将会用具体行动加以证明。
    史克·必诚公司是由美国史克贝克曼及英国必诚公司合并后组建的新公司，总部设在伦敦，是世界第二大制药公司。史克·必诚公司与中方合资，建有天津史克制药公司。
    温特一行是应中国国际信托投资公司的邀请来华访问的。
